摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2',3'-Di-O-acetyl-5'-deoxy-5'-(methylthio)adenosine | 119771-17-4

中文名称
——
中文别名
——
英文名称
2',3'-Di-O-acetyl-5'-deoxy-5'-(methylthio)adenosine
英文别名
2',3'-Di-O-acetyl-5'-S-methyl-5'-thioadenosine;[(2S,3S,4R,5R)-4-acetyloxy-5-(6-aminopurin-9-yl)-2-(methylsulfanylmethyl)oxolan-3-yl] acetate
2',3'-Di-O-acetyl-5'-deoxy-5'-(methylthio)adenosine化学式
CAS
119771-17-4
化学式
C15H19N5O5S
mdl
——
分子量
381.412
InChiKey
DXQNSDOONUEPIA-SDBHATRESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    26
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    157
  • 氢给体数:
    1
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2',3'-Di-O-acetyl-5'-deoxy-5'-(methylthio)adenosine三氯化锑 吡啶 、 (diethylamido)sulfur trifluoride 、 间氯过氧苯甲酸 作用下, 以 二氯甲烷 为溶剂, 反应 19.5h, 生成 2',3'-Di-O-acetyl-5'-O-methyl-5'-(methylthio)adenosine
    参考文献:
    名称:
    Nucleic Acid Related Compounds. 80. Synthesis of 5'-S-(Alkyl and aryl)-5'-fluoro-5'-thioadenosines with Xenon Difluoride or (Diethylamido)sulfur Trifluoride, Hydrolysis in Aqueous Buffer, and Inhibition of S-Adenosyl-L-homocysteine hydrolase by derived "Adenosine 5'-Aldehyde" Species
    摘要:
    Treatment of 5/-S-(alkyl and aryl)-5'-thioadenosine derivatives 2 with XeF2, or the corresponding sulfoxides 3 with DAST/SbCl3, gave diastereomeric 5'-fluoro compounds which were deprotected to give the 5'-S-(alkyl and aryl)-5'-fluoro-5'-thioadenosine analogues 5. Stereochemistry was established by X-ray crystallography, and F-19 NMR chemical shifts were definitive for configurationally-related 5'-fluoro diastereomers. Sulfoxidation and thermolysis afforded the fluoromethylene analogues with retained relative configuration. The nucleoside 5'-alpha-fluoro thioethers 5 underwent spontaneous hydrolysis in aqueous buffer to give derived ''adenosine 5'-aldehyde'' species which caused potent time-dependent inactivation of S-adenosyl-L-homocysteine hydrolase.
    DOI:
    10.1021/jo00082a010
  • 作为产物:
    参考文献:
    名称:
    5'-脱氧-5'-(甲硫基)腺苷的新型5'-氟化类似物的合成和抗增殖作用。
    摘要:
    5'-脱氧-5'-[(单氟甲基)硫代]腺苷(9)和5'-脱氧-5'-氟-5'-(甲硫基)腺苷(10),这是5'-脱氧-5的两个新类似物已经合成了'-(甲硫基)腺苷(MTA)并评估了它们对MTA磷酸化酶的底物和抑制活性,以及​​它们在L1210(MTA磷酸化酶缺陷)和L5178Y(含MTA磷酸化酶)鼠白血病细胞系中的生物学作用。化合物9是一种有效的MTA磷酸化酶竞争性抑制剂,Ki值为3.3 microM,并且还是一种底物,其活性约为MTA的53%。化合物10对磷酸化酶的抑制作用明显较小,Ki值为141 microM。其底物活性的缺乏归因于快速的非酶降解。在L1210和L5178Y细胞中,9的50%生长抑制浓度(48 h)分别为300和200 microM。对于10,这些各自的值为2和0.7 microM。这些系统中9的初始特征表明,它与MTA的不同之处在于它不充当多胺生物合成途径的产物调节剂。
    DOI:
    10.1021/jm00125a012
点击查看最新优质反应信息

文献信息

  • [EN] PHARMACEUTICAL AGENTS, COMPOSITIONS, AND METHODS RELATING THERETO<br/>[FR] AGENTS PHARMACEUTIQUES, COMPOSITIONS ET PROCÉDÉS ASSOCIÉS
    申请人:ALLTECH INC
    公开号:WO2018212980A1
    公开(公告)日:2018-11-22
    The present disclosure provides compounds of formulas (l)-(3), and compositions and methods of use thereof. The present disclosure also provides methods of preparing a provided compound and composition, and methods of characterizing a provided compound and composition.
    本公开提供了以下化合物的结构式(l)-(3),以及它们的组合物和使用方法。本公开还提供了制备所述化合物和组合物的方法,以及表征所述化合物和组合物的方法。
  • Synthesis of fluorinated derivatives of methionine and 5′-deoxy-5′-(methylthio)-adenosine using the mccarthy transformation of sulfoxides to α-fluoro thioethers
    作者:Janice R. Sufrin、Arthur J. Spiess、Vitauts Alks
    DOI:10.1016/s0022-1139(00)80377-2
    日期:1990.8
    trifluoride (DAST) or dimethylaminosulfur trifluoride (meDAST) yielded N-acetyl-S-(monofluoromethyl)homocysteine methyl ester as the sole fluorinated product. In contrast, treatment of 2′,3′-di-O-acetyl-5′-(methylthio)adenosine sulfoxide with DAST or meDAST unexpectedly produced three novel fluorinated products.
    二乙基基三DAST)或二甲基基三(meDAST)处理N-乙酰甲酸亚砜甲酯,得到的N-乙酰基-S-(单甲基)高半胱酸甲酯是唯一的化产物。相反,用DAST或meDAST处理2',3'-二-O-乙酰基-5'-(甲基)腺苷亚砜意外地产生了三种新颖的化产物。
  • Fluorination of 5′-deoxy-5′-(methylthio)adenosine with xenon difluoride provides an expedient synthesis of (fluoromethylthio)adenosine
    作者:Georges Guillerm、Marie Gâtel
    DOI:10.1039/p19940000153
    日期:——
    Fluorination of 5′-deoxy-5′-(fluoromethylthio)adenosine derivatives with xenon difluoride at –60 °C in dichloromethane occurs exclusively at the methylthio position to provide a simple and efficient preparation of 5′-deoxy-5′-(fluoromethylthio)adenosine.
    在–60°C的二氯甲烷中,化二对5'-脱氧-5'-(基)腺苷生物化仅在甲基位置发生,以提供简单有效的5'-脱氧-5'-(基)制备方法腺苷
  • Antitrypanosomal activity of purine nucleosides can be enhanced by their conversion to O-acetylated derivatives
    作者:J R Sufrin、D Rattendi、A J Spiess、S Lane、C J Marasco、C J Bacchi
    DOI:10.1128/aac.40.11.2567
    日期:1996.11

    Fifteen purine nucleosides and their O-acetylated ester derivatives were examined for in vitro antitrypanosomal activity against the LAB 110 EATRO isolate of Trypanosoma brucei brucei and two clinical isolates of Trypanosoma brucei rhodesiense. Initial comparisons of activity were made for the LAB 110 EATRO isolate. Three nucleoside analogs exhibited no significant activity (50% inhibitory concentrations [IC50s] of > 100 microM), whether they were O acetylated or unacetylated; three nucleosides showed almost equal activity (IC50s of < 5 microM) for the parent compound and the O-acetylated derivative; nine nucleosides showed significantly improved activity (> or = 3-fold) upon O acetylation; of these nine analogs, six displayed activity at least 10-fold greater than that of their parent nucleosides. The most significant results were those for four apparently inactive compounds which, upon O acetylation, displayed IC50s of < or = 25 microM. When the series of compounds was tested against T. brucei rhodesiense isolates (KETRI 243 and KETRI 269), their antitrypanosomal effects were comparable to those observed for the EATRO 110 strain. Thus, our studies of purine nucleosides have determined that O acetylation consistently improved their in vitro antitrypanosomal activity. This observed phenomenon was independent of their cellular enzyme targets (i.e., S-adenosylmethionine, polyamine, or purine salvage pathways). On the basis of our results, the routine preparation of O-acetylated purine nucleosides for in vitro screening of antitrypanosomal activity is recommended, since O acetylation transformed several inactive nucleosides into compounds with significant activity, presumably by improving uptake characteristics. O-acetylated purine nucleosides may offer in vivo therapeutic advantages compared with their parent nucleosides, and this possibility should be considered in future evaluations of this structural class of trypanocides.

    本研究对15种嘌呤核苷及其O-乙酰化酯衍生物在体外抗非洲锥虫病活性方面进行了研究,包括LAB 110 EATRO亚型的Trypanosoma brucei brucei和两种Trypanosoma brucei rhodesiense的临床分离株。首先比较了LAB 110 EATRO亚型的活性。其中三种核苷类似物没有显著活性(50%抑制浓度[IC50]大于100微米),无论它们是否被乙酰化;三种核苷显示出几乎相等的活性(IC50小于5微米)的母化合物和O-乙酰化衍生物;九种核苷在O-乙酰化后显示出显著改善的活性(大于或等于3倍);在这九种类似物中,有六种显示出至少比其母核苷高10倍的活性。最显着的结果是四个表面上无活性的化合物,在O-乙酰化后显示出IC50小于或等于25微米的活性。当这一系列化合物对T. brucei rhodesiense分离物(KETRI 243和KETRI 269)进行测试时,它们的抗非洲锥虫病效果与EATRO 110株观察到的相当。因此,我们对嘌呤核苷的研究确定了O-乙酰化一直改善它们的体外抗非洲锥虫病活性。这种观察到的现象与它们的细胞酶靶点(即S-腺苷酸、多胺嘌呤拯救途径)无关。基于我们的结果,建议常规制备O-乙酰化嘌呤核苷进行体外筛选抗非洲锥虫病活性,因为O-乙酰化将几种无活性的核苷转化为具有显著活性的化合物,可能通过改善摄取特性。与其母核苷比较,O-乙酰化嘌呤核苷在体内治疗上可能具有优势,这一可能性应在对这种结构类的锥虫药物进行未来评估时予以考虑。
  • Nucleic acid related compounds. 79. Efficient conversions of thioethers to .alpha.-fluoro thioethers with DAST or DAST/antimony(III) chloride
    作者:Morris J. Robins、Stanislaw F. Wnuk
    DOI:10.1021/jo00067a009
    日期:1993.7
    Dialkyl or alkyl aryl thioethers, including nucleoside thioethers, undergo virtually quantitative conversion to alpha-fluoro thioethers with (diethylamino)sulfur trifluoride (DAST) in dichloromethane at ambient temperature. Antimony(III) chloride catalyzes the process.
查看更多

同类化合物

阿糖胞苷杂质6 西奈芬净 腺苷硒基蛋氨酸 脱氧腺嘌呤核苷 甲硫腺苷 环西奈芬净 异丙基2-((2R,3S,4R,5R)-5-(6-氨基-9H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基)乙酸酯 尿嘧啶多氧菌素 C 多氧菌素 去氧氟尿苷 卡培他滨杂质N 卡培他滨杂质 卡培他滨中间体1 卡培他滨USP杂质 卡培他滨USP杂质 卡培他滨USP杂质 卡培他滨-d11 卡培他滨 化合物55 加洛他滨 [2-(癸酰氨基)-3-羟基-3-苯基丙基]N-[2-[[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基氨基]-2-氧代乙基]氨基甲酸酯 [(3R,4R,5R)-2-(6-氨基-8-叠氮基嘌呤-9-基)-5-甲基-4-(2,4,6-三硝基苯氧基)四氢呋喃-3-基]氧基二氢磷酸酯 S-腺苷蛋氨酸对甲苯磺酸硫酸盐 S-腺苷蛋氨酸丁二磺酸盐 S-腺苷蛋氨酸 S-腺苷甲硫氨酸对甲苯磺酸盐 S-腺苷基-L-蛋氨碘盐 S-腺苷乙硫氨酸 S-腺苷-L-蛋氨酸 S-腺苷-L-半胱氨酸 S-腺苷-3-硫代丙胺 S-腺苷-3-甲硫基丙胺 S-甲基-5'-甲硫基腺苷 S-次黄苷基高半胱氨酸 S-N(6)-甲基腺苷高半胱氨酸 S-(5’-腺苷基)-L-氯化蛋氨酸 S-(5'-腺苷)-L-高半胱氨酸 N-双环[2.2.1]-2-庚基-5-氯-5-脱氧腺苷酸 N-[6-[2-[[(2S,3S,4R,5R)-3,4-二羟基-5-[6-[(4-硝基苯基)甲基氨基]嘌呤-9-基]四氢呋喃-2-基]甲硫基]乙基氨基]-6-氧代己基]-3',6'-二羟基-3-氧代螺[2-苯并呋喃-1,9'-氧杂蒽]-5-甲酰胺 N(4)-腺苷-N(4)-甲基-2,4-二氨基丁酸 9-{5-[(3-氨基-3-羧基丙基)(甲基)-lambda4-硫基]-5-脱氧呋喃戊糖基}-9H-嘌呤-6-胺 9-[(2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基]-3H-嘌呤-2,6-二酮 9-(5-脱氧-beta-D-核-呋喃己糖基)-9H-嘌呤-6-胺 9-(5',6'-二脱氧-beta-己-5'-炔呋喃核糖基)腺嘌呤 8-氨基[1”-(N”-丹磺酰)-4”-氨基丁基]-5’-(1-氮丙啶基)-5’-脱氧腺苷 8-叠氮基-S-腺苷蛋氨酸 6-氯-9-(5-脱氧-D-呋喃核糖基)-9H-嘌呤 6-氨基-9-(5-脱氧-alpha-D-呋喃木糖基)-9H-嘌呤 5′-氨基-5′-脱氧腺苷对甲苯磺酸盐 5’-脱氧-5-氟胞嘧啶核苷